The Biomedical Sequencing Facility at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna is looking for a highly motivated bioinformatician who wants to…
The Indiana University School of Medicine in Indianapolis, IN is seeking candidates for an Associate/Full Professor of Medicine in Pulmonary, Critical Care, Sleep & Occupational Medicine. This is a…
Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy. https://www.bloomberg.com/tosv2.html?vid=&uuid=5f85f540-709e-11ec-ba6d-7a4e6c536f6b&url=L25ld3MvYXJ0aWNsZXMvMjAyMi0wMS0wOC9wYWxpaGFwaXRpeWEtbGVkLXNwYWMtc2FpZC10by1kaXNjdXNzLWFraWxpLWludGVyYWN0aXZlLWRlYWw=
The saying goes necessity is the mother of invention — and few areas of drug development are in greater need than oncology. A new startup is now repurposing promising technology to tackle the hardest…
Regeneron has held high hopes for evinacumab, a rare cholesterol disorder drug that earned a first-in-class nod from the FDA early last year, as a centerpiece of its cardiometabolic franchise. Now,…
A district court in Texas will likely tie up the FDA’s FOIA office for months, as the court ruled late Thursday that the agency must release all documents related to its review of Pfizer-BioNTech’s…
New year, same Fujifilm Diosynth. The CDMO giant hit the ground running at full speed this year, announcing it will expand its BioProcess Innovation Center in Research Triangle Park, NC. The move will…
Aligos Therapeutics took a beating Thursday after reporting it is stopping development on its lead program for chronic hepatitis B. The biotech’s shares $ALGS closed down 57% and fell into penny stock…
Physicians want both less and more from pharma companies – less promotional content but also more relevant and scientific information. And they’d rather dial into a webinar to get that information…
After 18 years at the FDA and climbing the corporate ladder in biopharma, Vicki Goodman is now in the biotech C-suite for the first time. The new CMO and executive VP of product development for…
